Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $41.03
- Value
- $83,455
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•70 filings
ALKS
Alkermes plc.
Net sales of $3.8M over the last 3 months
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$3,752,026
0 buyers · 4 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$10,278,918
7 distinct insiders
Highlighted alerts
2
32 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get ALKS insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ALKS overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
34
Voluntary view
P/S trades after deterministic checks
78
Administrative noise
Stored, never alerted
37
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- F
- Shares
- 4,069
- Price
- $40.11
- Footnotes
- 2
Each restricted stock unit represents a contingent right to receive one ordinary share. Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 10/8/2026.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $48.01
- Value
- $97,652
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 9,000
- Price
- $46.99
- Value
- $422,874
Nichols Christian Todd
SVP, Chief Commercial Officer
Sale 10b5-1
- Shares
- 664
- Price
- $49.65
- Value
- $32,969
Nichols Christian Todd
SVP, Chief Commercial Officer
Sale 10b5-1
- Shares
- 6,912
- Price
- $49.19
- Value
- $339,967
snyderman nancy lynn MD
Director
SaleAlert
- Shares
- 44,472
- Price
- $50.35
- Value
- $2,239,076
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 9,000
- Price
- $48.58
- Value
- $437,220
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $48.58
- Value
- $98,812
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $54.03
- Value
- $109,897
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 700
- Price
- $52.13
- Value
- $36,492
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 8,300
- Price
- $51.46
- Value
- $427,129
Wright Christopher I
Director
Sale 10b5-1
- Shares
- 2,000
- Price
- $45.10
- Value
- $90,200
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $43.05
- Value
- $87,564
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 9,000
- Price
- $41.67
- Value
- $375,044
Parisi Samuel Joseph
VP, Finance (Interim PAO)
SaleAlert
- Shares
- 16,217
- Price
- $42.36
- Value
- $687,007
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $33.20
- Value
- $67,529
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 9,000
- Price
- $33.40
- Value
- $300,560
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $34.57
- Value
- $70,315
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 9,000
- Price
- $35.51
- Value
- $319,604
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $29.76
- Value
- $60,532
Parisi Samuel Joseph
VP, Finance (Interim PAO)
Sale 10b5-1
- Shares
- 6,890
- Price
- $29.29
- Value
- $201,808
Nichols Christian Todd
SVP, Chief Commercial Officer
Sale 10b5-1
- Shares
- 6,000
- Price
- $30.00
- Value
- $180,000
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 9,000
- Price
- $29.72
- Value
- $267,485
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale 10b5-1
- Shares
- 2,034
- Price
- $29.29
- Value
- $59,576
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 4,000
- Price
- $33.54
- Value
- $134,160
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 5,000
- Price
- $34.24
- Value
- $171,225
Cooke Shane
Director
Sale 10b5-1
- Shares
- 32,113
- Price
- $34.78
- Value
- $1,116,877
Cooke Shane
Director
Sale 10b5-1
- Shares
- 29,087
- Price
- $34.34
- Value
- $998,795
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 5,000
- Price
- $30.00
- Value
- $150,005
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 4,000
- Price
- $28.00
- Value
- $112,000
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 3,748
- Price
- $30.00
- Value
- $112,447
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 4,000
- Price
- $29.30
- Value
- $117,200
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 9,000
- Price
- $30.38
- Value
- $273,442
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale 10b5-1
- Shares
- 9,000
- Price
- $31.53
- Value
- $283,776
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 02, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $41.03 | $83,455 | |
| Sep 03, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $48.01 | $97,652 | |
| Sep 01, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 9,000 | $46.99 | $422,874 | |
| Aug 17, 2026 | Nichols Christian Todd SVP, Chief Commercial Officer | Sale | 664 | $49.65 | $32,969 | |
| Aug 17, 2026 | Nichols Christian Todd SVP, Chief Commercial Officer | Sale | 6,912 | $49.19 | $339,967 | |
| Aug 03, 2026 | snyderman nancy lynn MD Director | Sale | 44,472 | $50.35 | $2,239,076 | |
| Aug 03, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 9,000 | $48.58 | $437,220 | |
| Aug 03, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $48.58 | $98,812 | |
| Jul 06, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $54.03 | $109,897 | |
| Jul 01, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 700 | $52.13 | $36,492 | |
| Jul 01, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 8,300 | $51.46 | $427,129 | |
| Jun 12, 2026 | Wright Christopher I Director | Sale | 2,000 | $45.10 | $90,200 | |
| Jun 04, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $43.05 | $87,564 | |
| Jun 01, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 9,000 | $41.67 | $375,044 | |
| May 29, 2026 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale | 16,217 | $42.36 | $687,007 | |
| May 04, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $33.20 | $67,529 | |
| May 01, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 9,000 | $33.40 | $300,560 | |
| Apr 06, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $34.57 | $70,315 | |
| Apr 01, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 9,000 | $35.51 | $319,604 | |
| Mar 03, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $29.76 | $60,532 | |
| Mar 02, 2026 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Sale | 6,890 | $29.29 | $201,808 | |
| Mar 02, 2026 | Nichols Christian Todd SVP, Chief Commercial Officer | Sale | 6,000 | $30.00 | $180,000 | |
| Mar 02, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 9,000 | $29.72 | $267,485 | |
| Mar 02, 2026 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sale | 2,034 | $29.29 | $59,576 | |
| Feb 02, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 4,000 | $33.54 | $134,160 | |
| Feb 02, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 5,000 | $34.24 | $171,225 | |
| Feb 02, 2026 | Cooke Shane Director | Sale | 32,113 | $34.78 | $1,116,877 | |
| Feb 02, 2026 | Cooke Shane Director | Sale | 29,087 | $34.34 | $998,795 | |
| Jan 08, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 5,000 | $30.00 | $150,005 | |
| Jan 02, 2026 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 4,000 | $28.00 | $112,000 | |
| Dec 03, 2025 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 3,748 | $30.00 | $112,447 | |
| Dec 01, 2025 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 4,000 | $29.30 | $117,200 | |
| Nov 03, 2025 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 9,000 | $30.38 | $273,442 | |
| Oct 15, 2025 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale | 9,000 | $31.53 | $283,776 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.